MBBS (Singapore) – M.Med (Singapore) – MRCP (United Kingdom) – FAMS (Medical Oncology)
Dr Tan Sing Huang is a Senior Consultant Medical Oncologist who has more than 16 years experience in managing a wide range of cancers. Prior to joining OncoCare Cancer Centre, she held the position of Senior Consultant in the Department of Hematology-Oncology National University Cancer Institute, Singapore (NCIS). She was also Assistant Professor, Yong Loo Lin School of Medicine, National University of Singapore.
During her work at NCIS, she had continued to take care of patients with a wide variety of cancers, including Breast cancers, Gynecological cancers, Lung cancers and Gastrointestinal cancers (colon, rectum, pancreas, liver, gastric) although her primary interest is in Women’s Cancers. As a result of her clinical efforts in NUH, she was awarded the Sunny Side-Up and Sunny Side-Up WOW Awards for exemplary patient feedback.
She led the Senior Residency Education division in NCIS as its Program Director since 2012 till 2016, served as Co-Chairman for the NCIS Clinical Competency Committee and also as panel member for national selection of Medical Oncology trainees. In addition, she participated as an examiner for undergraduate final medical exams. As a result of her contributions to education, she was awarded the NUH Teaching Excellence Award in 2014.
She held the post of Vice President of the Singapore Society of Oncology since 2013 till 2018.
She is also a long-standing current active Committee Member and more recently Deputy Chair of the National Healthcare Group Domain-Specific Ethics Review Board since 2020 which reviews Medical Oncology clinical trial protocols for the hospitals.
She was also principal investigator of several multi-center studies investigating new investigational drugs in HER2-positive breast cancers as well as being co-investigator of several multi-centre clinical trials in lung, colorectal and breast cancers.
Her interest in translational research led to spending time with the RUNX research group in Singapore under a National Medical Research-Singapore (NMRC) Totalisator Medical Research Fellowship Award. She then went to Johns Hopkins Sidney Kimmel Comprehensive Cancer Centre in Baltimore in 2006-2007 where she was involved in epigenetics research and also gained clinical experience from attachments with the Breast Cancer Division of Johns Hopkins Medical Institute.
She has been awarded the Research-Investigator-Scientist Enabler (RISE) Grant Scheme Award from 2008 to 2010, and the Junior Investigator Protected Time Award in 2011.She won a Merit Award for her Oral Presentation at the 10th International Conference of The Asian Clinical Oncology Society in Seoul on oncogenic mutation profiling changes pre- and post-chemotherapy in breast cancers. She was given the National Medical Research Council Clinician Investigator Salary Support Program (CISSP) Award from 2012 to 2014. She went on to obtain a number of independent grants since 2008 studying methylation patterns, high-throughput oncogenic mutation profiling and the effects of chemotherapy on cognition in cancer patients.
She has contributed chapters on chemotherapy treatment of metastatic breast cancer in international textbooks such as Diseases of the Breast. In addition, she has written and contributed to publications which have appeared in local and international journals including Clinical Cancer Research and Annals of Oncology.
She has also given many local and overseas talks as an invited speaker including in China, Vietnam and Brunei. She has also chaired conferences and been an invited speaker for both local and overseas conferences. She is fluent in English, Mandarin and Hokkien and is able to speak some Malay and Bahasa. She has taken care of patients from many regional and overseas regions including Indonesia, Vietnam, Myanmar, China, Bangladesh, Sri Lanka, India and Russia.